This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Carvedilol

Authoring team

Carvedilol is a mixed beta- and alpha-1 adrenoceptor antagonist.

Carvedilol has been licensed for treatment of:

  • hypertension:
    • doses 6.25 to 25 mg twice daily

  • symptomatic heart failure:
    • in patients with stable heart failure
    • mild to moderate symptoms (NYHA II to III)
    • start on 3.125 mg twice daily for two weeks
    • double dose at 2 weekly intervals to the maximum of 25 mg twice daily (1)

Check the summary of product characteristics before prescribing this drug.

Reference:

  • Packer, M. et al. (1996). The effect of Carvedilol on morbidity and mortality in patients with chronic heart failure. New Engl. J. Med. 334, 1349-55.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.